Is Ultragenyx Pharmaceutical Inc. (RARE) a Buy, Sell, or Hold?
NASDAQ : RARE
Ultragenyx Pharmaceutical Inc. — Competitors
$24.91 USD
-$1.13 (-4.34%)
- Volume
- 1.54M
- Average Volume
- 2.19M
- Market Capitalization
- $2.45B
- P/E Ratio
- -4.08
- Dividend Yield
- 0.00%
- Price Target
- $43.00
- Year High
- $39.89
- Year Low
- $18.29
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.02
RARE vs. The Competition
| Properties | RARE | AAPG | APGE | CELC |
|---|---|---|---|---|
| Market Cap | $2.45B | $1.62B | $8.3B | $4.21B |
| Shares Outstanding | $98.49M | $92.96M | $61.88M | $48.77M |
| P/E Ratio | -4.08 | -8.49 | -30.97 | -22.21 |
| EPS | -6.06 | -13.29 | -3.94 | -3.54 |
| Day Low | 24.6 | 17.2401 | 134.05 | 85.46 |
| Day High | 26.075 | 17.6 | 134.37 | 88.5 |
| Year Low | 18.29 | 16.36 | 34.34 | 38.93 |
| Year High | 39.89 | 48.45 | 134.46 | 151.02 |
| Average Price 50 | 27.4045 | 18.47554 | 112.7672 | 100.539 |
| Average Price 200 | 27.01393 | 24.87754 | 82.9341 | 103.7226 |
| Volume | 1.54M | 3720 | 1.74M | 677.93K |
| Average Volume | - | - | - | - |